A San Antonio company is trying to break into the pharmaceutical market with a new version of an old drug that it believes offers hope to two-legged and four-legged patients diagnosed with incurable or life-altering diseases.
A San Antonio company is trying to break into the pharmaceutical market with a new version of an old drug that it believes offers hope to two-legged and four-legged patients diagnosed with incurable or life-altering diseases.